- Are between 18 and 80 years of age;
- Have MS;
- Have UI due to MS;
- Have not responded well to oral medications; and
- Are routinely performing clean intermittent catherization.
~~ Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.
Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Wednesday, October 4, 2017
This is a clinical trial for Patients with Urinary Incontinence, who have Multiple Sclerosis…
If you or a loved one experience MS-related urinary incontinence (UI), or involuntary urine leakage, new options may be available.
Clinical trials help to find new treatments for a variety of conditions, such as UI due to MS, and we would like to let you know about a new trial that is now enrolling.
This trial is testing whether Dysport®, which is already approved for other conditions, can help reduce UI in people living with MS for whom oral medications have not worked well.
You or your loved one may be able to take part if you or he/she:
To learn more and to see if you or your loved one may be able to take part, please click here.
As you may know, MS Views and News (MSVN) , several months ago, partnered with Antidote, a digital health company, to offer a new clinical trial search tool on our website that will make learning about and connecting with MS clinical trials easier than ever. If this UI trial is not of interest to you, we encourage you to check out the search tool and learn more about other MS-related research trials in your area.
Antidote is a digital health company that provides access to the latest clinical trials. Antidote’s match tool makes it simple for anyone to search and learn more about condition-specific clinical trials in an effort to make medical research more accessible to everyone.
MS Views and News (MSVN) does not endorse or have any control or relationship with the service being provide